Every earnings call for KIMS — management tone, guidance, KPIs and promise tracking, quarter by quarter.
KIMS · 6 transcripts · Healthcare · latest Q4 FY26Krishna Institute of Medical Sciences Limited has 6 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Revenue (Q4 FY26) ₹1,084 cr (+35% YoY); EBITDA (Q4 FY26) ₹216 cr (+7% YoY); EBITDA Margin (Q4 FY26) 19.9%. Q4 FY26 Revenue of INR 1,084 crore, up 35.3% YoY.
Read full transcript & analysisRevenue from Operations ₹998 cr (+29% YoY); EBITDA Margin 20.4%; PAT ₹52 cr (−44% YoY). Record-breaking quarterly revenue crossing the ₹1,000 crore mark for the first time, reaching ₹1,003 crores.
Read full transcript & analysisTotal Revenue ₹965 cr (+23% YoY); EBITDA ₹208 cr (−7% YoY); EBITDA Margin 21.6%. Total Revenue reached ₹965 crores, a growth of 23.3% YoY and 9.8% QoQ.
Read full transcript & analysisTotal Revenue ₹879 cr (+27% YoY); EBITDA ₹200 cr (+8% YoY); EBITDA Margin 22.7%. Total revenue reached ₹879 crores, representing a 26.8% YoY growth and 9.6% QoQ growth.
Read full transcript & analysisRevenue ₹801 cr (+26% YoY); EBITDA Margin 25.3% (−0% YoY); PAT ₹106 cr (+47% YoY). Full Year FY25 Revenue reached ₹3,067 crores, representing a 22% YoY growth.
Read full transcript & analysisRevenue from Operations ₹772 cr (+28% YoY); EBITDA ₹205 cr (+36% YoY); EBITDA Margin 25.9%. Gross revenue reached ₹790 crores, representing a 29.7% YoY growth and 1% QoQ increase.
Read full transcript & analysis